Skip to main content
PMC home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1998 Feb 24;158(4):475–480.

The delay to thrombolysis: an analysis of patient and hospital characteristics

J M Brophy 1, J G Diodati 1, P Bogaty 1, P Théroux 1
PMCID: PMC1228920  PMID: 9627559

Abstract

OBJECTIVE: To describe the various components of the delay to thrombolytic treatment for patients with acute myocardial infarction (MI) and to identify the hospital and patient characteristics related to these delays. DESIGN: Cohort analysis from a hospital registry of patients receiving thrombolytic treatment. SETTING: Forty acute care hospitals in Quebec. SUBJECTS: All 1357 patients who received thrombolysis between January 1995 and May 1996. MAIN OUTCOME MEASURES: Time from onset of symptoms to arrival at hospital and the various components of the in-hospital delay. RESULTS: The median delay before presentation to hospital was 98 (interquartile range [IR] 56 to 180) minutes and was longer for women (p < 0.001), patients over 65 years of age (p < 0.001) and patients with diabetes mellitus (p < 0.01). The median time from arrival at hospital to thrombolysis was 59 (IR 41 to 89) minutes, the medical decision-making component taking a median of 12 (IR 4 to 27) minutes. Women (p < 0.005), older patients (p < 0.001) and patients with a past history of MI (p < 0.001) had increased in-hospital delays to thrombolysis. Delays were longer in community hospitals (p < 0.05) and low-volume centres (p < 0.01) and when a cardiologist made the decision to administer thrombolysis (p < 0.001). Multivariate analysis showed that increased age (odds ratio 1.5, 95% confidence interval 1.3 to 1.7, p < 0.001) and having the medical decision made by a cardiologist (odds ratio 1.8, 95% confidence interval 1.6 to 2.0, p < 0.001) were independently associated with an increased risk of being in the upper median of in-hospital delays. CONCLUSIONS: Despite certain improvements, there remain substantial delays between symptom onset and the administration of thrombolysis for patients with acute MI. A large part of the delay is due to the hesitation of patients (particularly women, older patients and patients with diabetes) to seek medical attention. Although the median time for medical decision-making appears reasonable, care must be taken to ensure that all patient groups receive timely evaluation and therapy. The delay associated with having the treatment decision made by a cardiologist probably represents a marker for more difficult, complex cases. Methods should be developed to permit specialty consultation, if needed, while minimizing treatment delays. Community and low-volume hospitals may require special attention.

Full Text

The Full Text of this article is available as a PDF (116.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ayanian J. Z., Hauptman P. J., Guadagnoli E., Antman E. M., Pashos C. L., McNeil B. J. Knowledge and practices of generalist and specialist physicians regarding drug therapy for acute myocardial infarction. N Engl J Med. 1994 Oct 27;331(17):1136–1142. doi: 10.1056/NEJM199410273311707. [DOI] [PubMed] [Google Scholar]
  2. Boersma E., Maas A. C., Deckers J. W., Simoons M. L. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet. 1996 Sep 21;348(9030):771–775. doi: 10.1016/S0140-6736(96)02514-7. [DOI] [PubMed] [Google Scholar]
  3. Brophy J. M., Joseph L. Placing trials in context using Bayesian analysis. GUSTO revisited by Reverend Bayes. JAMA. 1995 Mar 15;273(11):871–875. [PubMed] [Google Scholar]
  4. Burnett R. E., Blumenthal J. A., Mark D. B., Leimberger J. D., Califf R. M. Distinguishing between early and late responders to symptoms of acute myocardial infarction. Am J Cardiol. 1995 May 15;75(15):1019–1022. doi: 10.1016/s0002-9149(99)80716-4. [DOI] [PubMed] [Google Scholar]
  5. Cairns J., Armstrong P., Belenkie I., Hirsh J., Johnstone D., Knudtson M., Lemieux M., Massel D., Naylor D., Roy L. Canadian Consensus Conference on Coronary Thrombolysis--1994 update. Can J Cardiol. 1994 Jun;10(5):517–521. [PubMed] [Google Scholar]
  6. Cox J. L., Lee E., Langer A., Armstrong P. W., Naylor C. D. Time to treatment with thrombolytic therapy: determinants and effect on short-term nonfatal outcomes of acute myocardial infarction. Canadian GUSTO Investigators. Global Utilization of Streptokinase and + PA for Occluded Coronary Arteries. CMAJ. 1997 Feb 15;156(4):497–505. [PMC free article] [PubMed] [Google Scholar]
  7. Diamond G. A., Forrester J. S. Clinical trials and statistical verdicts: probable grounds for appeal. Ann Intern Med. 1983 Mar;98(3):385–394. doi: 10.7326/0003-4819-98-3-385. [DOI] [PubMed] [Google Scholar]
  8. Hannan E. L., Kilburn H., Jr, Bernard H., O'Donnell J. F., Lukacik G., Shields E. P. Coronary artery bypass surgery: the relationship between inhospital mortality rate and surgical volume after controlling for clinical risk factors. Med Care. 1991 Nov;29(11):1094–1107. [PubMed] [Google Scholar]
  9. Jollis J. G., DeLong E. R., Peterson E. D., Muhlbaier L. H., Fortin D. F., Califf R. M., Mark D. B. Outcome of acute myocardial infarction according to the specialty of the admitting physician. N Engl J Med. 1996 Dec 19;335(25):1880–1887. doi: 10.1056/NEJM199612193352505. [DOI] [PubMed] [Google Scholar]
  10. Kimmel S. E., Berlin J. A., Laskey W. K. The relationship between coronary angioplasty procedure volume and major complications. JAMA. 1995 Oct 11;274(14):1137–1142. [PubMed] [Google Scholar]
  11. Letovsky E., Allen T. Initiating thrombolytic therapy for acute myocardial infarction: whose job is it anyway? CMAJ. 1996 Feb 15;154(4):509–511. [PMC free article] [PubMed] [Google Scholar]
  12. Newby L. K., Rutsch W. R., Califf R. M., Simoons M. L., Aylward P. E., Armstrong P. W., Woodlief L. H., Lee K. L., Topol E. J., Van de Werf F. Time from symptom onset to treatment and outcomes after thrombolytic therapy. GUSTO-1 Investigators. J Am Coll Cardiol. 1996 Jun;27(7):1646–1655. doi: 10.1016/0735-1097(96)00053-8. [DOI] [PubMed] [Google Scholar]
  13. Rogers W. J., Bowlby L. J., Chandra N. C., French W. J., Gore J. M., Lambrew C. T., Rubison R. M., Tiefenbrunn A. J., Weaver W. D. Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction. Circulation. 1994 Oct;90(4):2103–2114. doi: 10.1161/01.cir.90.4.2103. [DOI] [PubMed] [Google Scholar]
  14. Wielgosz A. T., Nolan R. P. Understanding delay in response to symptoms of acute myocardial infarction. A compelling agenda. Circulation. 1991 Nov;84(5):2193–2195. doi: 10.1161/01.cir.84.5.2193. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES